PhenixFIN Corp Files Q4 2024 10-Q

TL;DR

PhenixFIN Corp (formerly Medley Capital) filed its 10-Q for Q4 2024. Check financials.

AI Summary

PhenixFIN Corporation filed its 10-Q for the quarterly period ended December 31, 2024. The company, formerly known as Medley Capital Corp, is incorporated in Delaware and its principal executive offices are located at 445 Park Avenue, New York, NY. The filing covers the period ending December 31, 2024, and was submitted on February 7, 2025.

Why It Matters

This filing provides investors with the latest financial performance and operational details of PhenixFIN Corporation for the fourth quarter of 2024.

Risk Assessment

Risk Level: low — This is a standard quarterly financial filing with no immediate red flags.

Key Players & Entities

• PhenixFIN Corporation (company) — Registrant
• Medley Capital Corp (company) — Former company name
• December 31, 2024 (date) — Quarterly period ended
• February 7, 2025 (date) — Filing date
• 445 Park Avenue, New York, NY (location) — Principal executive offices

FAQ

Key Financial Figures

• $0.001 — ich registered Common Stock, par value $0.001 per share PFX The NASDAQ Global Market
• $333,268,547 — . The tax cost basis of investments is $333,268,547 as of December 31, 2024. The amortized
• $162,771,930 — 5) Percentage is based on net assets of $162,771,930 as of December 31, 2024. (6) Affiliate

Filing Documents

• ea0229161-10q_phenixfin.htm (10-Q) — 3309KB
• ea022916101ex10-15_phenixfin.htm (EX-10.15) — 54KB
• ea022916101ex31-1_phenixfin.htm (EX-31.1) — 7KB
• ea022916101ex31-2_phenixfin.htm (EX-31.2) — 7KB
• ea022916101ex32-1_phenixfin.htm (EX-32.1) — 8KB
• 0001213900-25-011052.txt ( ) — 13695KB
• pfx-20241231.xsd (EX-101.SCH) — 91KB
• pfx-20241231_cal.xml (EX-101.CAL) — 44KB
• pfx-20241231_def.xml (EX-101.DEF) — 419KB
• pfx-20241231_lab.xml (EX-101.LAB) — 636KB
• pfx-20241231_pre.xml (EX-101.PRE) — 439KB
• ea0229161-10q_phenixfin_htm.xml (XML) — 3116KB

SIGNATURES

SIGNATURES 63 i PHENIXFIN CORPORATION Consolidated December 31, 2024 (Unaudited) September 30, 2024 Assets: Investments at fair value Non-controlled, non-affiliated investments (amortized cost of $ 160,480,488 and $ 143,179,354 respectively) $ 160,343,098 $ 142,233,426 Affiliated investments (amortized cost of $ 20,564,242 and $ 20,564,242 , respectively) 13,861,599 14,750,785 Controlled investments (amortized cost of $ 152,223,817 and $ 97,016,429 , respectively) 125,889,697 70,931,647 Total Investments at fair value 300,094,394 227,915,858 Cash and cash equivalents 7,187,110 67,571,559 Receivables: Interest receivable 1,313,520 1,313,598 Other receivable 16,640 65,838 Dividends receivable 105,804 23,468 Due from Affiliate 1,040,512 90,500 Deferred tax asset 887,099 887,099 Deferred financing costs 625,323 760,680 Other assets 514,630 1,066,323 Prepaid share repurchase 101,115 101,115 Receivable for investments sold 41,897 2,955,775 Total Assets $ 311,928,044 $ 302,751,813 Liabilities: Credit facility and notes payable (net of debt issuance costs of $ 1,417,816 and $ 1,510,815 , respectively) $ 141,743,682 $ 135,723,636 Payable for investments purchased 3,688,247 - Accounts payable and accrued expenses 2,391,430 5,570,150 Interest and fees payable 1,029,334 768,043 Other liabilities 256,426 294,063 Due to Affiliate 46,995 88,148 Total Liabilities 149,156,114 142,444,040 Commitments and Contingencies (see Note 8) Net Assets: Common Shares, $ 0.001 par value; 5,000,000 shares authorized; 2,723,709 shares issued; 2,019,778 and 2,019,778 common shares outstanding, respectively 2,020 2,020 Capital in excess of par value 704,909,588 704,909,588 Total distributable earnings (loss) ( 542,139,678 ) ( 544,603,835 ) Total Net Assets 162,771,930 160,307,773 Total Liabilities and Net Assets $ 311,928,044 $ 30

View Full Filing

View this 10-Q filing on SEC EDGAR